CBHD Stock Overview
Engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 1/6 |
| Dividends | 3/6 |
Coloplast A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | DKK 117.80 |
| 52 Week High | DKK 130.45 |
| 52 Week Low | DKK 92.76 |
| Beta | 0.33 |
| 11 Month Change | -3.84% |
| 3 Month Change | 4.06% |
| 1 Year Change | 17.80% |
| 33 Year Change | -13.64% |
| 5 Year Change | 8.22% |
| Change since IPO | 1,410.26% |
Recent News & Updates
Recent updates
Shareholder Returns
| CBHD | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -3.4% | 3.1% | 1.0% |
| 1Y | 17.8% | 4.8% | 11.2% |
Return vs Industry: CBHD exceeded the German Medical Equipment industry which returned 0.4% over the past year.
Return vs Market: CBHD exceeded the German Market which returned 10.7% over the past year.
Price Volatility
| CBHD volatility | |
|---|---|
| CBHD Average Weekly Movement | 3.6% |
| Medical Equipment Industry Average Movement | 5.0% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 11.6% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: CBHD has not had significant price volatility in the past 3 months.
Volatility Over Time: CBHD's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1954 | 16,019 | Kristian Villumsen | www.coloplast.com |
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand.
Coloplast A/S Fundamentals Summary
| CBHD fundamental statistics | |
|---|---|
| Market cap | €26.49b |
| Earnings (TTM) | €665.82m |
| Revenue (TTM) | €3.53b |
39.8x
P/E Ratio7.5x
P/S RatioIs CBHD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CBHD income statement (TTM) | |
|---|---|
| Revenue | DKK 26.30b |
| Cost of Revenue | DKK 8.54b |
| Gross Profit | DKK 17.76b |
| Other Expenses | DKK 12.79b |
| Earnings | DKK 4.97b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 05, 2024
| Earnings per share (EPS) | 22.09 |
| Gross Margin | 67.52% |
| Net Profit Margin | 18.88% |
| Debt/Equity Ratio | 142.3% |
How did CBHD perform over the long term?
See historical performance and comparison